Sociedad Americana de Hirudoterapia

Leech therapy for symptomatic treatment of knee osteoarthritis: results and implications of a pilot study

Michalsen A, Moebus S, Spahn G, Esch T, Langhorst J, Dobos GJ (2002) · Alternative Therapies in Health and Medicine · n=16

Detalle de evidencia de RCTReferencia del ensayo
GRADE muy bajaEvidencia insuficienteCondición: Knee Osteoarthritis →
Tamaño de muestra de este ensayo en comparación con otros ensayos de Knee OsteoarthritisWang H 2018264Lauche R 2025240Lauche R 2014237Lauche R 2014237Farzali S 2025181Cui Y 2024144Andereya S 2008113Andereya S 2008113Isik M 201790Michalsen A 200216
Este ensayo (destacado) por tamaño de muestra junto a otros ensayos indexados de Knee Osteoarthritis. Los ensayos más grandes generalmente tienen mayor peso estadístico.

Perfil del estudio

Diseño
single-center, observational, controlled, non-randomized pilot study (Essen, Germany)
Tamaño de la muestra (n)
16
Intervención
Single trial of 4 Hirudo medicinalis leeches applied topically at painful periarticular sites of the knee joint
Comparador
Conventional inpatient pain treatment excluding NSAIDs (n=6 control inpatients)
Punto final primario
Self-reported general knee pain on visual analog scale, daily for 10 days and follow-up at day 28
Resultado primario
Periarticular application of 4 leeches produced rapid pain relief with sustained improvement at 4 weeks; no major complications observed (descriptive analysis given small n)
Duración del seguimiento
28 days

Hallazgos clave

  • First modern controlled pilot study of leech therapy in knee OA — predecessor to the landmark Michalsen 2003 RCT
  • Established the protocol of single-session 4-leech periarticular application later used across the Essen program
  • Pain reduction onset within days of single session in 10 leech-treated inpatients
  • No serious adverse events; treatment well tolerated in elderly OA inpatients (mean age 69 years)
  • Provided the proof-of-concept and effect-size estimate that powered the 2003 RCT

Limitaciones

  • Non-randomized, observational design — high risk of selection bias
  • Very small sample (n=16; 10 leech vs 6 control)
  • Open-label inpatient setting — strong attention and expectancy effects
  • No biomarker or imaging endpoints
  • Single center (Kliniken Essen-Mitte) — same group that ran subsequent RCTs

Implicaciones clínicas

Michalsen 2002 is the foundational pilot study of the modern hirudotherapy evidence base. It established the periarticular 4-leech single-session protocol that became standard in subsequent German trials. Methodologically it is a controlled but non-randomized pilot; clinicians should cite it as historical context rather than as evidence of efficacy. Its principal value is documenting the safety and feasibility signal that motivated the funding and design of Michalsen 2003 — and through that, the entire subsequent line of European RCTs.

Estudios relacionados

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.